Literature DB >> 19088518

Parental report of medication acceptance among youth: implications for everyday practice.

Jodi Polaha1, William T Dalton, Blake M Lancaster.   

Abstract

OBJECTIVE: Evidence-based interventions for pill swallowing training exist but are primarily implemented in pediatric specialty hospitals. Given increasing interest in the translation of brief and effective interventions to the wider population, there is a need to examine medication acceptance in a normative sample.
METHODS: Participants (N = 304) completed the Medication Acceptance Survey, which assessed child/adolescent liquid and pill medication history and acceptance as well as parental interest in pill swallowing training.
RESULTS: Results showed that 30-40% of youth had rejected/refused a pill or liquid formulation. Over half were unable to swallow a standard size pill or small capsule. Despite these difficulties, most parents did not express interest in an empirically supported pill swallowing training intervention.
CONCLUSIONS: The results provide directions for future research as well as the translation of pill swallowing interventions to primary care.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19088518     DOI: 10.1097/SMJ.0b013e318180645d

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  10 in total

1.  Relationship between bitter-taste receptor genotype and solid medication formulation usage among young children: a retrospective analysis.

Authors:  Sarah V Lipchock; Danielle R Reed; Julie A Mennella
Journal:  Clin Ther       Date:  2012-03       Impact factor: 3.393

2.  Development of oil-based gels as versatile drug delivery systems for pediatric applications.

Authors:  Ameya R Kirtane; Christina Karavasili; Aniket Wahane; Dylan Freitas; Katelyn Booz; Dao Thi Hong Le; Tiffany Hua; Stephen Scala; Aaron Lopes; Kaitlyn Hess; Joy Collins; Siddartha Tamang; Keiko Ishida; Johannes L P Kuosmanen; Netra Unni Rajesh; Nhi V Phan; Junwei Li; Annlyse Krogmann; Jochen K Lennerz; Alison Hayward; Robert Langer; Giovanni Traverso
Journal:  Sci Adv       Date:  2022-05-27       Impact factor: 14.957

3.  NWP06, an extended-release oral suspension of methylphenidate, improved attention-deficit/hyperactivity disorder symptoms compared with placebo in a laboratory classroom study.

Authors:  Sharon B Wigal; Ann C Childress; Heidi W Belden; Sally A Berry
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-01-05       Impact factor: 2.576

4.  Children's perceptions about medicines: individual differences and taste.

Authors:  Julie A Mennella; Kristi M Roberts; Phoebe S Mathew; Danielle R Reed
Journal:  BMC Pediatr       Date:  2015-09-21       Impact factor: 2.125

Review 5.  Patient-centred pharmaceutical design to improve acceptability of medicines: similarities and differences in paediatric and geriatric populations.

Authors:  Fang Liu; Sejal Ranmal; Hannah K Batchelor; Mine Orlu-Gul; Terry B Ernest; Iwan W Thomas; Talia Flanagan; Catherine Tuleu
Journal:  Drugs       Date:  2014-10       Impact factor: 9.546

6.  Efficacy and Safety of a Chewable Methylphenidate Extended-Release Tablet in Children with Attention-Deficit/Hyperactivity Disorder.

Authors:  Sharon B Wigal; Ann Childress; Sally A Berry; Heidi Belden; Faith Walters; Phillip Chappell; Nancy Sherman; John Orazem; Donna Palumbo
Journal:  J Child Adolesc Psychopharmacol       Date:  2017-05-30       Impact factor: 2.576

Review 7.  Methylphenidate extended-release oral suspension for the treatment of attention-deficit/hyperactivity disorder: a practical guide for pharmacists.

Authors:  Joshua Caballero; Edress H Darsey; Faith Walters; Heidi W Belden
Journal:  Integr Pharm Res Pract       Date:  2017-10-17

8.  A Single-Dose, Single-Period Pharmacokinetic Assessment of an Extended-Release Orally Disintegrating Tablet of Methylphenidate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.

Authors:  Ann Childress; Jeffrey Newcorn; Jeffrey G Stark; Russ McMahen; Mark Tengler; Carolyn Sikes
Journal:  J Child Adolesc Psychopharmacol       Date:  2016-05-26       Impact factor: 2.576

9.  Pharmacokinetic Profile and Palatability of Atomoxetine Oral Solution in Healthy Japanese Male Adults.

Authors:  Masako Nakano; Jennifer Witcher; Yoichi Satoi; Taro Goto
Journal:  Clin Drug Investig       Date:  2016-11       Impact factor: 2.859

10.  Efficacy, Safety, and Tolerability of an Extended-Release Orally Disintegrating Methylphenidate Tablet in Children 6-12 Years of Age with Attention-Deficit/Hyperactivity Disorder in the Laboratory Classroom Setting.

Authors:  Ann C Childress; Scott H Kollins; Andrew J Cutler; Andrea Marraffino; Carolyn R Sikes
Journal:  J Child Adolesc Psychopharmacol       Date:  2016-05-16       Impact factor: 2.576

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.